Celldex Therapeutics (CLDX) Operating Margin Growth (1y) (2011 - 2026)
Celldex Therapeutics (CLDX) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Celldex Therapeutics |
2.16 Bn |
2.16 Bn |
-1.44 Mn |
-55.39 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-55.39 Mn |
| Dec 31, 2025 |
-6.73 Mn |
| Jun 30, 2025 |
-689,337.00 |
| Mar 31, 2025 |
1.70 Mn |
| Dec 31, 2024 |
-361,534.00 |
| Sep 30, 2024 |
108,493.00 |
| Jun 30, 2024 |
1.05 Mn |
| Mar 31, 2024 |
-2.27 Mn |
| Dec 31, 2023 |
57,585.00 |
| Sep 30, 2023 |
408,646.00 |
| Jun 30, 2023 |
993,891.00 |
| Mar 31, 2023 |
1.00 Mn |
| Dec 31, 2022 |
-1.25 Mn |
| Sep 30, 2022 |
680,554.00 |
| Jun 30, 2022 |
-2.19 Mn |
| Mar 31, 2022 |
-1.09 Mn |
| Dec 31, 2021 |
1.14 Mn |
| Sep 30, 2021 |
-1.15 Mn |
| Jun 30, 2021 |
442,947.00 |
| Mar 31, 2021 |
-171,422.00 |
